What is Duvelisib: Uses, Dosage, Side Effects and More

Duvelisib is a targeted cancer medication that helps treat certain types of blood cancers by blocking specific proteins that help cancer cells grow and survive. Your doctor might prescribe this oral medication if you have chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that hasn't responded well to other treatments. This medication represents a newer approach to cancer treatment that works differently from traditional chemotherapy.

What is Duvelisib?

Duvelisib is a prescription medication that belongs to a class of drugs called PI3K inhibitors. It works by targeting and blocking two specific enzymes (PI3K-delta and PI3K-gamma) that cancer cells need to grow, multiply, and spread throughout your body.

The medication comes as oral capsules that you take by mouth, making it more convenient than intravenous cancer treatments. It's specifically designed for people with certain blood cancers who have tried at least two other treatments without success.

This targeted therapy approach means the medication focuses on attacking cancer cells while potentially causing less damage to healthy cells compared to traditional chemotherapy. However, like all cancer medications, it still requires careful monitoring by your healthcare team.

What is Duvelisib Used For?

Duvelisib is approved to treat two specific types of blood cancer: chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). These conditions occur when certain white blood cells called lymphocytes become cancerous and multiply uncontrollably.

Your doctor will typically consider duvelisib when you've already tried at least two other cancer treatments that didn't work well enough or stopped working. This makes it what doctors call a "third-line" treatment option for these particular cancers.

The medication is also used for relapsed or refractory follicular lymphoma, which means the cancer has either come back after treatment or hasn't responded to previous therapies. Your oncologist will determine if duvelisib is right for your specific situation based on your medical history and current condition.

How Does Duvelisib Work?

Duvelisib works by blocking two important signaling pathways that cancer cells use to survive and grow. Think of these pathways like fuel lines that feed the cancer - when you block them, the cancer cells struggle to maintain themselves.

The medication specifically targets PI3K-delta and PI3K-gamma enzymes, which are overactive in many blood cancers. By inhibiting these enzymes, duvelisib disrupts the cancer cells' ability to receive growth signals, avoid cell death, and create new blood vessels to feed tumors.

This is considered a moderately strong cancer medication that requires careful monitoring. While it's generally better tolerated than traditional chemotherapy, it can still cause significant side effects because it affects your immune system's normal function.

How Should I Take Duvelisib?

Take duvelisib exactly as your doctor prescribes, typically twice daily with or without food. You can take it with water, milk, or juice - whatever feels most comfortable for your stomach.

It's best to take your doses at roughly the same times each day to maintain steady levels in your bloodstream. Many people find it helpful to set phone reminders or link their doses to regular daily activities like breakfast and dinner.

Don't crush, chew, or break the capsules - swallow them whole. If you have trouble swallowing pills, talk to your doctor about strategies that might help, but never alter the capsules themselves.

You don't need to eat specific foods before taking duvelisib, but taking it with food might help reduce stomach upset if you experience nausea. Some people find that eating something bland like crackers or toast helps their stomach feel more settled.

How Long Should I Take Duvelisib For?

You'll typically continue taking duvelisib for as long as it's helping control your cancer and you're tolerating it reasonably well. This could mean months or even years, depending on how your body responds to the treatment.

Your doctor will monitor your progress through regular blood tests, scans, and check-ups to see how well the medication is working. They'll also watch for side effects that might require adjusting your dose or taking breaks from treatment.

Some people need temporary dose reductions or treatment breaks if they develop serious side effects. Your healthcare team will work with you to find the right balance between controlling your cancer and maintaining your quality of life.

Never stop taking duvelisib without talking to your doctor first, even if you're feeling better. Cancer medications work best when taken consistently as prescribed.

What Are the Side Effects of Duvelisib?

Like all cancer medications, duvelisib can cause side effects, though not everyone experiences them. The most common side effects happen because the medication affects your immune system and digestive tract.

Here are the side effects you're most likely to encounter, keeping in mind that many people manage these successfully with proper support:

• Diarrhea (often the most troublesome side effect)
• Nausea and vomiting
• Decreased appetite
• Fatigue and weakness
• Fever
• Cough
• Rash or skin problems
• Upper respiratory tract infections

Your doctor will monitor you closely for these effects and can provide medications or strategies to help manage them. Most side effects are manageable with proper care and attention.

There are also some more serious but less common side effects that require immediate medical attention. While these are rarer, it's important to be aware of them:

• Severe diarrhea that doesn't improve with treatment
• Signs of serious infection (high fever, chills, persistent cough)
• Severe skin reactions or rash
• Lung inflammation (pneumonitis)
• Severe colitis (intestinal inflammation)
• Unusual bruising or bleeding
• Yellowing of skin or eyes

Contact your healthcare team immediately if you experience any of these serious symptoms. They're trained to help you manage these effects and will adjust your treatment plan if needed.

Who Should Not Take Duvelisib?

Duvelisib isn't suitable for everyone, and your doctor will carefully review your medical history before prescribing it. Certain conditions or situations make this medication potentially dangerous or less effective.

You should not take duvelisib if you have a known allergy to the medication or any of its ingredients. Your doctor will also be cautious if you have active, serious infections since the medication can weaken your immune system further.

People with severe liver problems may need dose adjustments or alternative treatments, as duvelisib is processed through the liver. Your doctor will check your liver function before starting treatment and monitor it regularly.

If you're pregnant or breastfeeding, duvelisib is not recommended as it could harm your baby. Women of childbearing age should use effective contraception during treatment and for at least one month after stopping the medication.

Your doctor will also consider other medications you're taking, as duvelisib can interact with certain drugs, particularly those that affect your immune system or are processed by the same liver enzymes.

Duvelisib Brand Name

Duvelisib is available under the brand name Copiktra in the United States. This is the only brand name currently available for this medication.

When you pick up your prescription, you'll see "Copiktra" on the bottle label along with the generic name "duvelisib." Both names refer to the same medication.

The medication is manufactured by Verastem Oncology and is available only through specialty pharmacies that handle cancer medications. Your doctor's office will typically help coordinate getting your prescription filled through the appropriate pharmacy.

Duvelisib Alternatives

If duvelisib isn't suitable for you or stops working effectively, several other treatment options exist for blood cancers like CLL and SLL. Your oncologist will help determine the best alternative based on your specific situation.

Other targeted therapies include ibrutinib (Imbruvica), acalabrutinib (Calquence), and venetoclax (Venclexta). These medications work through different mechanisms but are also designed to target specific pathways in cancer cells.

Traditional chemotherapy combinations like FCR (fludarabine, cyclophosphamide, rituximab) or BR (bendamustine, rituximab) might also be options, depending on your age, overall health, and previous treatments.

Newer immunotherapy approaches, including CAR-T cell therapy, might be considered for certain patients with relapsed or refractory disease. Your healthcare team will discuss all available options and help you understand the benefits and risks of each.

Is Duvelisib Better Than Ibrutinib?

Both duvelisib and ibrutinib are effective targeted therapies for blood cancers, but they work through different mechanisms and have different side effect profiles. Neither is universally "better" than the other - the choice depends on your individual circumstances.

Ibrutinib has been available longer and has more extensive clinical data supporting its use. It's often used earlier in the treatment sequence, while duvelisib is typically reserved for patients who have tried multiple other treatments.

The side effect profiles differ significantly between these medications. Ibrutinib is more likely to cause heart rhythm problems and bleeding issues, while duvelisib more commonly causes severe diarrhea and immune system complications.

Your doctor will consider factors like your other medical conditions, previous treatments, and personal preferences when choosing between these options. Some patients do better with one medication over the other, and this often becomes clear only after trying the treatment.